A Fatal Case of Persistent Bacteremia and Acute Cholecystitis Caused by : A Case Report

Overview

Journal IDCases

Specialty Infectious Diseases

Date 2023 Jan 27

PMID 36704024

Authors

Yoshiro Hadano

Toshiyuki Hijikata

Affiliations

Soon will be listed here.

Abstract

Biliary tract infections caused by are rare. Here, we describe a case of fatal acute cholecystitis and persistent bacteremia caused by in a patient with newly diagnosed diabetes mellitus. can cause bacteremic biliary tract infections, which are associated with higher mortality rates compared to biliary bacteremia. Early aggressive treatment and consultations with infectious disease specialists are recommended when biliary bacteremia is clinically suspected.

Citing Articles

Pathophysiological consequences and treatment strategy of obstructive jaundice.

Liu J, Sun Y, Xu Y, Mei H, Guo W, Li Z World J Gastrointest Surg. 2023; 15(7):1262-1276.

PMID: 37555128 PMC: 10405123. DOI: 10.4240/wjgs.v15.i7.1262.

References

Yang E, Lee J, Seo H, Chung H, Ra S, Sung H . Clinical characteristics and outcomes of Staphylococcus aureus bacteremia from a biliary source. Eur J Clin Microbiol Infect Dis. 2020; 39(10):1951-1957. DOI: 10.1007/s10096-020-03940-6. View

Miura F, Okamoto K, Takada T, Strasberg S, Asbun H, Pitt H . Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2017; 25(1):31-40. DOI: 10.1002/jhbp.509. View

Yu A, Cun T, Benamu E, Renault C . Persistent bacteraemia caused by in the gall bladder. BMJ Case Rep. 2017; 2017. PMC: 5695395. DOI: 10.1136/bcr-2017-220656. View

Karakonstantis S, Kalemaki D . Evaluation and management of Staphylococcus aureus bacteriuria: an updated review. Infection. 2017; 46(3):293-301. DOI: 10.1007/s15010-017-1100-6. View

Strasberg S . Clinical practice. Acute calculous cholecystitis. N Engl J Med. 2008; 358(26):2804-11. DOI: 10.1056/NEJMcp0800929. View

Martin J, Miller D, Menard G . Treatment considerations for recurrent MRSA bacteremia leading to cholecystitis. J Gen Intern Med. 2011; 26(6):669-72. PMC: 3101964. DOI: 10.1007/s11606-011-1634-8. View

Van Hal S, Jensen S, Vaska V, Espedido B, Paterson D, Gosbell I . Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev. 2012; 25(2):362-86. PMC: 3346297. DOI: 10.1128/CMR.05022-11. View

Honda H, Krauss M, Jones J, Olsen M, Warren D . The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med. 2010; 123(7):631-7. PMC: 3606273. DOI: 10.1016/j.amjmed.2010.01.015. View

Nagao M, Yamamoto M, Matsumura Y, Yokota I, Takakura S, Teramukai S . Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis. Infection. 2016; 45(1):83-91. DOI: 10.1007/s15010-016-0946-3. View

10.

French A, Beaudet L, Benator D, Levy C, Kass M, Orenstein J . Cholecystectomy in patients with AIDS: clinicopathologic correlations in 107 cases. Clin Infect Dis. 1995; 21(4):852-8. DOI: 10.1093/clinids/21.4.852. View

11.

Kim J, Gregson D, Church D . A case of acute cholecystitis caused by methicillin-resistant Staphylococcus aureus in an immunocompromised patient. Can J Infect Dis Med Microbiol. 2012; 22(1):e7-9. PMC: 3076155. DOI: 10.1155/2011/202078. View

12.

Gomi H, Solomkin J, Schlossberg D, Okamoto K, Takada T, Strasberg S . Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2017; 25(1):3-16. DOI: 10.1002/jhbp.518. View

13.

Holland T, Arnold C, Fowler Jr V . Clinical management of Staphylococcus aureus bacteremia: a review. JAMA. 2014; 312(13):1330-41. PMC: 4263314. DOI: 10.1001/jama.2014.9743. View

14.

Hadano Y, Kakuma T, Matsumoto T, Ishibashi K, Isoda M, Yasunaga H . Reduction of 30-day death rates from Staphylococcus aureus bacteremia by mandatory infectious diseases consultation: Comparative study interventions with and without an infectious disease specialist. Int J Infect Dis. 2020; 103:308-315. DOI: 10.1016/j.ijid.2020.11.199. View

15.

Lopez-Cortes L, Toro M, Galvez-Acebal J, Bereciartua-Bastarrica E, Farinas M, Sanz-Franco M . Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013; 57(9):1225-33. DOI: 10.1093/cid/cit499. View

16.

Brook I . Aerobic and anaerobic microbiology of biliary tract disease. J Clin Microbiol. 1989; 27(10):2373-5. PMC: 267027. DOI: 10.1128/jcm.27.10.2373-2375.1989. View

17.

Nepal S, Giri S, Panday K . Successful treatment of methicillin-resistant Staphylococcus aureus bacteraemia and cholecystitis. BMJ Case Rep. 2012; 2012. PMC: 4544898. DOI: 10.1136/bcr-2012-007281. View